Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
CSL joins with the global bleeding disorders community – including women and girls – to support empowerment and access to tre…
Human plasma is a precious resource needed to make lifesaving medicines. That’s why CSL Plasma, one of the world’s leading co…
A rare condition, HAE, causes unpredictable swelling attacks that can be life-threatening. Day-to-day, patients live with the…
The research doesn’t stop just because a new treatment has been approved for use by patients. We talked with CSL’s Andres Bra…
In honor of Rare Disease Day, we asked patients and caregivers how others can best support them as they manage complex medica…
On Rare Disease Day, the Immune Deficiency Foundation (IDF) will screen the patient-focused film, “Compromised: Life Without …
On February 28, CSL will illuminate landmarks in the United States, Switzerland and Germany. “Take a few moments to reflect o…
For patients who live with rare diseases, making new friends – especially other patients – can lift, nourish and inspire.
Kids in a rare disease research trial deserve extra care. That’s why CSL decided to be the first ever to provide “Clinical Co…
Americas
Asia Pacific
Middle East
Europe
